Romlusevimab Antibody
Romlusevimab (BRII-198) is a recombinant human monoclonal antibody designed for research on SARS-CoV-2. It binds to the viral spike protein, exhibiting neutralizing activity in vitro. This makes it a tool for investigating COVID-19 mechanisms and potential therapeutic applications in preclinical studies.
Product Specifications
Product Name Alternative
BRII198, BRII-198
Target
SARS-CoV
Clonality
Recombinant
Conjugation
Unconjugated
Field of Research
Infectious Disease & Virology
Concentration
14.09 mg/mL
Purity
100.00% (May vary between batches)
Molecular Weight
143.4 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
RC215050L1V 200 µL
NLRP14 (NM_176822) Human Tagged ORF Clone Lentiviral Particle
Sign In for Pricing
View Details 
ELK5527 96 Tests
ELISA kit for Human UCHL1 (Ubiquitin Carboxyl Terminal Hydrolase L1)
Sign In for Pricing
View Details MBS6149843-01 0.1 mL
SOX21 (Transcription Factor SOX-21, SOX-A, SOX25, SOXA) (FITC)
Sign In for Pricing
View Details MBS6149843-02 5x 0.1 mL
SOX21 (Transcription Factor SOX-21, SOX-A, SOX25, SOXA) (FITC)
Sign In for Pricing
View Details